Biotage AB (publ)
BITGFOTCHealthcare
$15.01
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$18.52
52W Low$11.5
Biotage AB (publ) (BITGF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BITGF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.06B | $1.86B | $1.57B | $1.23B | $1.09B |
| Cost of Revenue | $0.77B | $0.71B | $0.62B | $0.48B | $0.43B |
| Gross Profit | $1.29B | $1.15B | $0.95B | $0.76B | $0.67B |
| Gross Margin %(computed) | 62.69% | 61.71% | 60.54% | 61.28% | 61.08% |
| Operating Expenses | |||||
| R&D Expenses | $0.18B | $0.16B | $0.11B | $0.09B | $0.07B |
| G&A Expenses | $0.23B | $0.19B | $0.15B | $0.12B | $0.10B |
| Total Operating Expenses | $0.91B | $0.83B | $0.62B | $0.48B | $0.46B |
| Operating Income | $0.38B | $0.31B | $0.33B | $0.27B | $0.21B |
| Operating Margin %(computed) | 18.63% | 16.86% | 20.88% | 22.00% | 18.86% |
| Interest Income | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.04B | $0.04B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.33B | $0.30B | $0.35B | $0.27B | $0.22B |
| Income Tax Expense | $0.04B | $0.06B | $0.08B | $0.06B | $0.05B |
| Net Income | $0.28B | $0.25B | $0.27B | $0.20B | $0.17B |
| Net Margin %(computed) | 13.81% | 13.21% | 17.11% | 16.64% | 16.03% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.55 | $3.34 | $4.06 | $3.13 | $2.68 |
| Wtd Avg Shares | 0.08B | 0.07B | 0.07B | 0.07B | 0.07B |
| EBITDA | $0.53B | $0.47B | $0.45B | $0.35B | $0.30B |
| EBITDA Margin %(computed) | 25.78% | 24.97% | 28.99% | 28.17% | 27.47% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · SEK · B
Explore more Biotage AB (publ) data
About Biotage AB (publ) (BITGF) Income Statement
Biotage AB (publ) (BITGF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, BITGF reported revenue of $2.06B, gross profit of $1.29B (gross margin 62.69%), and net income of $0.28B — a net profit margin of 13.81%.
Frequently asked questions
BITGF · 4 questionsBiotage AB (publ) (BITGF) reported revenue of $2.06B for 2024, up 10.4% year-over-year.
BITGF revenueBITGF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08